alternative investments Archives

Cabot Undervalued Stocks Advisor Special Bulletin

August 23, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

A Spanish news outlet, Intereconomia.com, is reporting that biotech company Amgen (AMGN) is in talks to buy Alexion Pharmaceuticals (ALXN) for close to $200 per share.
Read More

Cabot Global Stocks Explorer 692

From the Cabot Global Stocks Explorer 692 issue of Cabot Global Stocks Explorer|by sarahd|Emerging Markets

Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

August 9, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Four stocks in our portfolios reported earnings this week.
Read More

Cabot Global Stocks Explorer 691

From the Cabot Global Stocks Explorer 691 issue of Cabot Global Stocks Explorer|by sarahd|Emerging Markets

Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More

Cabot Dividend Investor 719

From the Cabot Dividend Investor 719 issue of Cabot Dividend Investor|by sueh|Dividend Stocks

The Dog Days of Summer We are in the dog days of summer, the hottest, most sultry days of the year. The expression “dog days” is an old one. In fact, it’s really old. The Romans used it. It’s one of those expressions that everyone but...
Read More

Cabot Global Stocks Explorer 690

From the Cabot Global Stocks Explorer 690 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More

Cabot Global Stocks Explorer 689

From the Cabot Global Stocks Explorer 689 issue of Cabot Global Stocks Explorer|by sarahd|Emerging Markets

Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More

Cabot Emerging Markets Investor 688

From the Cabot Emerging Markets Investor 688 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 687

From the Cabot Emerging Markets Investor 687 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 686

From the Cabot Emerging Markets Investor 686 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 685

From the Cabot Emerging Markets Investor 685 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 684

From the Cabot Emerging Markets Investor 684 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 683

From the Cabot Emerging Markets Investor 683 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 682

From the Cabot Emerging Markets Investor 682 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 681

From the Cabot Emerging Markets Investor 681 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 680

From the Cabot Emerging Markets Investor 680 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 679

From the Cabot Emerging Markets Investor 679 issue of Cabot Global Stocks Explorer|by sarahd|Emerging Markets

Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More

Cabot Emerging Markets Investor 678

From the Cabot Emerging Markets Investor 678 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

We’re not going to say emerging market stocks are showing any real strength, but there are a few encouraging signs out there—the iShares EM Fund (EEM) has stopped underperforming U.S. markets during the past couple of months, and even during the selloff of past...
Read More

Cabot Emerging Markets Investor 677

From the Cabot Emerging Markets Investor 677 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

We’re not going to say emerging market stocks are showing any real strength, but there are a few encouraging signs out there—the iShares EM Fund (EEM) has stopped underperforming U.S. markets during the past couple of months, and even during the selloff of past...
Read More

Cabot Emerging Markets Investor 676

From the Cabot Emerging Markets Investor 676 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

We’re not going to say emerging market stocks are showing any real strength, but there are a few encouraging signs out there—the iShares EM Fund (EEM) has stopped underperforming U.S. markets during the past couple of months, and even during the selloff of past...
Read More